Obesity drug supply-demand imbalance is working in Novo Nordisk’s favor: Mizuho’s Jared Holz

Obesity drug supply-demand imbalance is working in Novo Nordisk’s favor: Mizuho’s Jared Holz

February 1, 2024

Share This

Jared Holz, Mizuho Securities, joins ‘Fast Money’ to talk demand in the obesity drug space and who is benefiting from the supply-demand imbalance.

Latest Mizuho News

Mizuho Expands “A Name Worth Knowing Award” to Support Two Promising Junior Golfers

Mizuho Expands “A Name Worth Knowing Award” to Support Two Promising Junior Golfers

May 8, 2026

Head of Investment and Corporate Banking Michal Katz on Bloomberg The Close (Starts at 1:15)

Head of Investment and Corporate Banking Michal Katz on Bloomberg The Close (Starts at 1:15)

April 29, 2026

All eyes on Coinbase after Robinhood's crypto revenue falls 47%

All eyes on Coinbase after Robinhood's crypto revenue falls 47%

May 5, 2026

Mizuho news from around the globe

Mizuho Global News